Latest filing published 26 Sept 2007 for NEW BRUNSWICK SCIENTIFIC CO INC, €8.0M.
No signal scores available.
This profile gathers the share dealings of David Freedman in New Brunswick Scientific Co Inc. Activity is concentrated on a single trading day, 24 September 2007, with 4 filings.
Every open-market trade on record is a sale: 4 sales worth €10.2M.
The latest filing, published on 26 September 2007, reports an open-market sale of €8.0M in New Brunswick Scientific Co Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations